Lymphocyte mitochondrial biomarkers in asymptomatic HIV-1-infected individuals treated with nucleoside reverse transcriptase inhibitors.
Henry
Keith
K
HIV Program Regions Hospital, St Paul, MN, USA.
Erice
Alejo
A
Balfour
Henry H
HH
Schmeling
Max
M
Berthiaume
Jessica
J
Wallace
Ken
K
D000328:Adult; D015415:Biomarkers / Q000032:analysis; D015331:Cohort Studies; D003573:Cytochrome b Group / Q000378:metabolism; D004272:DNA, Mitochondrial / Q000378:metabolism; D015658:HIV Infections / Q000188:drug therapy*; D054303:HIV Reverse Transcriptase / Q000037:antagonists & inhibitors; D015497:HIV-1; D006801:Humans; D008214:Lymphocytes / Q000378:metabolism / Q000821:virology; D008875:Middle Aged; D028361:Mitochondrial Diseases / Q000139:chemically induced*; D009705:Nucleosides; D011770:Pyruvate Kinase / Q000378:metabolism; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*
D015415:Biomarkers; D003573:Cytochrome b Group; D004272:DNA, Mitochondrial; D009705:Nucleosides; D018894:Reverse Transcriptase Inhibitors; D011770:Pyruvate Kinase; D054303:HIV Reverse Transcriptase